AGTX
Price
$0.02
Change
-$0.01 (-33.33%)
Updated
Jul 23 closing price
Capitalization
841.41K
BCYC
Price
$8.70
Change
+$0.10 (+1.16%)
Updated
Jul 25 closing price
Capitalization
602.51M
4 days until earnings call
Interact to see
Advertisement

AGTX vs BCYC

Header iconAGTX vs BCYC Comparison
Open Charts AGTX vs BCYCBanner chart's image
Agentix
Price$0.02
Change-$0.01 (-33.33%)
Volume$7K
Capitalization841.41K
Bicycle Therapeutics
Price$8.70
Change+$0.10 (+1.16%)
Volume$306.84K
Capitalization602.51M
AGTX vs BCYC Comparison Chart in %
Loading...
AGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGTX vs. BCYC commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGTX is a Hold and BCYC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (AGTX: $0.02 vs. BCYC: $8.70)
Brand notoriety: AGTX and BCYC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGTX: 20% vs. BCYC: 111%
Market capitalization -- AGTX: $841.41K vs. BCYC: $602.51M
AGTX [@Biotechnology] is valued at $841.41K. BCYC’s [@Biotechnology] market capitalization is $602.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGTX’s FA Score shows that 1 FA rating(s) are green whileBCYC’s FA Score has 1 green FA rating(s).

  • AGTX’s FA Score: 1 green, 4 red.
  • BCYC’s FA Score: 1 green, 4 red.
According to our system of comparison, BCYC is a better buy in the long-term than AGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGTX’s TA Score shows that 3 TA indicator(s) are bullish while BCYC’s TA Score has 6 bullish TA indicator(s).

  • AGTX’s TA Score: 3 bullish, 2 bearish.
  • BCYC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than AGTX.

Price Growth

AGTX (@Biotechnology) experienced а -28.69% price change this week, while BCYC (@Biotechnology) price change was +1.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

AGTX is expected to report earnings on Jul 16, 2025.

BCYC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($603M) has a higher market cap than AGTX($841K). BCYC YTD gains are higher at: -37.857 vs. AGTX (-88.167). AGTX has higher annual earnings (EBITDA): -352.07K vs. BCYC (-200.61M). BCYC has more cash in the bank: 793M vs. AGTX (8.27K). AGTX has less debt than BCYC: AGTX (198K) vs BCYC (8.33M). BCYC has higher revenues than AGTX: BCYC (25.7M) vs AGTX (0).
AGTXBCYCAGTX / BCYC
Capitalization841K603M0%
EBITDA-352.07K-200.61M0%
Gain YTD-88.167-37.857233%
P/E RatioN/AN/A-
Revenue025.7M-
Total Cash8.27K793M0%
Total Debt198K8.33M2%
FUNDAMENTALS RATINGS
AGTX vs BCYC: Fundamental Ratings
AGTX
BCYC
OUTLOOK RATING
1..100
8237
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
9761
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5045

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGTX's Valuation (3) in the null industry is in the same range as BCYC (21). This means that AGTX’s stock grew similarly to BCYC’s over the last 12 months.

AGTX's Profit vs Risk Rating (100) in the null industry is in the same range as BCYC (100). This means that AGTX’s stock grew similarly to BCYC’s over the last 12 months.

BCYC's SMR Rating (96) in the null industry is in the same range as AGTX (100). This means that BCYC’s stock grew similarly to AGTX’s over the last 12 months.

BCYC's Price Growth Rating (61) in the null industry is somewhat better than the same rating for AGTX (97). This means that BCYC’s stock grew somewhat faster than AGTX’s over the last 12 months.

BCYC's P/E Growth Rating (100) in the null industry is in the same range as AGTX (100). This means that BCYC’s stock grew similarly to AGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGTXBCYC
RSI
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 21 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
AGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PESPX29.280.26
+0.90%
BNY Mellon MidCap Index Inv
QCSGX21.290.17
+0.80%
Federated Hermes MDT Small Cap Growth C
POIIX16.680.12
+0.72%
Polen International Growth Institutional
FDETX28.030.11
+0.39%
Fidelity Advisor Capital Development O
WGISX15.09-0.01
-0.07%
Wasatch International Select Instl

AGTX and

Correlation & Price change

A.I.dvisor tells us that AGTX and RLAY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGTX and RLAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGTX
1D Price
Change %
AGTX100%
N/A
RLAY - AGTX
32%
Poorly correlated
+1.63%
RVMD - AGTX
28%
Poorly correlated
+1.84%
SKYE - AGTX
23%
Poorly correlated
-2.49%
ALGS - AGTX
23%
Poorly correlated
+2.47%
BCYC - AGTX
22%
Poorly correlated
+1.16%
More

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+1.16%
XNCR - BCYC
54%
Loosely correlated
N/A
RPTX - BCYC
50%
Loosely correlated
+0.65%
RLAY - BCYC
48%
Loosely correlated
+1.63%
INO - BCYC
48%
Loosely correlated
-2.65%
RCUS - BCYC
44%
Loosely correlated
+3.65%
More